Taken together, these data indicate that the CD39+ Treg subset in colon tumors is more dynamic compared to the CD39− Treg subset, with a higher degree of proliferation and a phenotype indicating a higher suppressive ability on a population basis. Here, ENTPD1 is linked to colonic neoplasm.